It was also demonstrated that FOXP3 promotes tumor growth and metastasis in tumor cells in NSCLC by activating the Wnt/β-catenin signaling pathway [35] and epithelial–mesenchymal transition (EMT) [35,36,55]. The gene discussed is FOXP3; the disease is neoplasm.